A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

Yifan Tu, Dawn L. Hershman, Kapil Bhalla, Warren Fiskus, Christine M. Pellegrino, Eleni Andreopoulou, Della Makower, Kevin Kalinsky, Karen Fehn, Susan Fineberg, Abdissa Negassa, Leslie L. Montgomery, Lisa S. Wiechmann, R. Katherine Alpaugh, Min Huang, Joseph A. Sparano

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences